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The transcription factor Sox9 is expressed in all chondroprogenitors
and has an essential role in chondrogenesis. Sox9 is also expressed in
other tissues, including central nervous system, neural crest, intestine,
pancreas, testis, and endocardial cushions, and plays a crucial role in
cell proliferation and differentiation in several of these tissues. To
determine the cell fate of Sox9-expressing cells during mouse em-
bryogenesis, we generated mice in which a Cre recombinase gene
preceded by an internal ribosome entry site was inserted into the 3
untranslated region of the Sox9 gene (Sox9-Cre knock-in). In the
developing skeleton, Sox9 was expressed before Runx2, an early
osteoblast marker gene. Cell fate mapping by usingSox9-Cre;ROSA26
reporter (R26R) mice revealed that Sox9-expressing limb bud mesen-
chymal cells gave rise to both chondrocytes and osteoblasts. Fur-
thermore, a mutant in which the Osterix gene was inactivated in
Sox9-expressing cells exhibited a lack of endochondral and intra-
membranous ossification and a lack of mature osteoblasts compara-
ble with Osterix-null mutants. In addition, Sox9-expressing limb bud
mesenchymal cells also contributed to tendon and synovium forma-
tion. By using Sox9-Cre;R26R mice, we also were able to systemati-
cally follow Sox9-expressing cells from embryonic day 8.0 to 17.0. Our
results showed that Sox9-expressing cells contributed to the forma-
tion of all cell types of the spinal cord, epithelium of the intestine,
pancreas, and mesenchyme of the testis. Thus, our results strongly
suggest that all osteo-chondroprogenitor cells, as well as progenitors
in a variety of tissues, are derived from Sox9-expressing precursors
during mouse embryogenesis.
chondrogenesis  Osterix  chondrocytes  osteoblasts
L imb skeleton is formed as a cartilage model that undergoesendochondral bone formation. At the initiation of limb
development, undifferentiated mesenchymal cells in the lateral
plate mesoderm receive proliferation signals from the apical
ectodermal ridge. These cells start to aggregate and form
mesenchymal condensations, which are the primordia of the limb
skeleton, then differentiate into chondrocytes and generate a
cartilage skeleton. Cells surrounding the nascent cartilage form
the perichondrium and periosteum, specialized structures con-
sisting of thin layers of mesenchymal cells. The cells surrounding
the zone of hypertrophic chondrocytes begin to differentiate into
osteoblasts and, together with blood vessels and osteoclasts,
invade the mineralized cartilage matrix and replace cartilage by
bone.
Specific transcription factors regulate the differentiation path-
ways of chondrocytes and osteoblasts. Sox9, a transcription
factor with a high-mobility group DNA-binding domain, acti-
vates chondrocyte-specific marker genes, such as Col2a1,
Col11a2, and Aggrecan (1–3). Sox9 is expressed in all chondro-
progenitors and chondrocytes except hypertrophic chondrocytes
(4, 5). Campomelic dysplasia, a human disease that is caused by
heterozygous mutations in the Sox9 gene, is characterized by a
general hypoplasia of endochondral bones (6, 7). We have
recently shown that inactivation of Sox9 in limb buds by using the
Cre recombinaseloxP recombination system before chondro-
genic mesenchymal condensations form results in the complete
absence of mesenchymal condensations and subsequent carti-
lage and bone formation (8). Moreover, inactivation of Sox9
during or after mesenchymal condensations results in a very
severe chondrodysplasia, which is characterized by an almost
complete absence of cartilage in the endochondral skeleton (8).
Hence, Sox9 is required at sequential steps in chondrogenesis
before and after mesenchymal condensations. These results also
suggest that Sox9 may be involved in the determination of both
chondrogenic and osteogenic cell lineages in limb development.
Runx2 is a member of the Runt-domain family of transcription
factors, which form heterodimers with a single ubiquitous
polypeptide called Cbfb (9). In addition to the Runx DNA-
binding domain, Runx2 contains an active transactivation do-
main, rich in glutamine and alanine residues, and activates the
Osteocalcin (Oc) and Col1a1 genes (10, 11). Cleidocranial dys-
plasia, a genetic disease in humans that is characterized by
hypoplastic clavicles, large open spaces between the frontal and
parietal bones of the skull, and other skeletal dysplasias, is
caused by heterozygous mutations in the Runx2 gene (12).
Runx2-null mice are characterized by a block in osteoblast
differentiation and the absence of both endochondral and
intramembranous bone formation, indicating that Runx2 has an
essential role in the differentiation of mesenchymal progenitors
into osteoblasts (10, 13, 14). Thus, Runx2 is an initial marker of
the osteogenic cell lineage.
Recently, we identified a second transcription factor required
for osteoblast differentiation, called Osterix (Osx) (15), that is
specifically expressed in osteoblasts of all endochondral and
membranous bones. Osx contains a DNA-binding domain con-
sisting of three C2H2-type zinc fingers at its C terminus that
share a high degree of sequence identity with similar motifs in
Spl, Sp3, and Sp4. In addition, Osx also contains a proline- and
serine-rich transactivation domain and activates the Oc and
Col1a1 genes. In Osx-null mutant mice, no endochondral or
intramembranous bone formation occurs (15). The mesenchy-
mal cells inOsx-null mutant mice do not deposit bonematrix, and
cells in the periosteum and the condensed mesenchyme of
membranous skeletal elements cannot differentiate into osteo-
blasts, although these cells express normal levels of Runx2.
Arrest in osteoblast differentiation in Osx-null mutant mice
occurs at a later step than that in Runx2-null mice. Indeed,
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expression of Osx requires Runx2, indicating that Osx acts
downstream of Runx2.
On the basis of our previous mouse genetic studies, we
hypothesized that Sox9 is expressed in osteo-chondroprogenitors
during endochondral bone formation before chondrogenic and
osteogenic cell lineages are distinct (8). To test this hypothesis,
we generated mice carrying the Cre recombinase gene inserted
into the 3-UTR of the Sox9 gene and crossed these mice with
the Rosa26 reporter (R26R) strain to follow the cell fate of
Sox9-expressing cells during limb development. We also crossed
this Cre line with mice carrying a floxed Osx allele to inactivate
the Osx gene in Sox9-expressing cells. Our results indicated that
Sox9 defines common progenitors of chondrogenic and osteo-
genic cell lineages.
Materials and Methods
Generation of Sox9-Cre Knock-In Mice and Floxed Osx Mice. A Sox9
clone was isolated from a mouse 129Sv genomic DNA library.
The targeting vector spanned a 7.7-kb fragment of the Sox9 gene
and an internal ribosome entry site (IRES)-Cre-pAFRT-flanked
PGK-neo-bpA cassette was inserted into a HpaI site within the
3-UTR in exon3. AnMC1-tk-pA herpes simplex virus thymidine
kinase expression cassette was added onto the 3 arm of homol-
ogy to enrich for homologous recombinants by negative selection
with 1-(2-deoxy-2-f luoro--D-arabinofuranosyl)-5-iodouracil
(FIAU). The targeting vector was introduced into 129SvEv AB1
mouse ES cells and G418FIAU-resistant ES cell clones were
initially screened by Southern blot analysis of BamHI-digested
genomic DNA by using a 3 probe external to the region of vector
homology. Mouse chimeras were generated by injection of
mutant ES cell clones into C57BL6 host blastocysts, and the
chimeras obtained were bred with C57BL6 mice to generate
Sox9-Cre knock-in heterozygous mice.
An Osx clone was also isolated from a mouse129Sv genomic
DNA library. To construct the targeting vector for the floxedOsx
allele, an 8.0-kb fragment was subcloned. Exon 2 was flanked by
two loxP sites; the first was in intron 1 and the second in the
3-f lanking region. An FRT-flanked PGK-neo-bpA cassette and
an IRES- EGFP-pA cassette, which contained a splicing acceptor
signal at the 5 end, were inserted into the BamHI site 3 to the
second loxP site. The target vector was introduced into 129SvEv
AB1 ES cells, and G418-resistant ES cell clones were initially
screened by Southern blot analysis of EcoRV-digested genomic
DNA with a 3 probe external to the region of homology.
Homologous recombination was verified by using a 5 probe
external to the region of homology. Mouse chimeras were
generated by C57BL6 host blastocyst injection of mutant ES
cell clones, and chimeras obtained were bred with C57BL6mice
to generate floxed Osx heterozygous mice. The FRT-flanked
PGK-neo-bpA cassette was removed by Flp-mediated recombi-
nation with ACTFlpe transgenic mice (16).
In a first cross, Sox9-Cre knock-in mice were mated with mice
heterozygous for the floxed Osx allele. The offspring inheriting
both the Cre recombinase gene and the floxed allele were then
mated with OsxlacZ/wt heterozygous mice (15) to obtain embryos
with the Osxflox/lacZ and the Sox9-Cre knock-in allele. Routine
mouse genotyping was performed by PCR. The following primer
pairs were used: f loxed Osx allele (5-CTTGGGAACACT-
GAAGCTGT-3 and 5-CTGTCTTCACCTCAATTCTATT-
3); Osx-lacZ allele (5-CGGATAAACGGAACTGGAAA-3
and 5-TAATCACGACGCGCTGTATC-3); and Sox9-Cre
knock-in allele (5-TCCAATTTACTGACCGTACACCAA-3
and 5-CCTGATCCTGGCAATTTCGGCTA-3).
Histological Analysis. -gal staining of embryos was performed as
described in ref. 17. For the histological analysis, embryos were
fixed with 4% paraformaldehyde and embedded in paraffin.
Sections of 7 mwere stained with alcian blue, hematoxylin, and
Treosin (Statlab, Lewisville, TX). Immunohistochemical stain-
ing of sections was performed by using peroxidase chromogens
(Zymed, South San Francisco, CA)TrueBlue substrate
(Kirkegaard & Perry Laboratories, Gaithersburg, MD) with
rabbit polyclonal anti-Sox9 antibody (1:100) (1). RNA in situ
hybridization analysis was carried out as described in ref. 8.
Pictures of hybridization signals were superimposed with blue
f luorescence images of cell nuclei stained with Hoechst
33258 dye.
Results
Generation of Sox9-Cre Knock-In Mice. To follow the fate of Sox9-
expressing cells throughout embryonic development, we gener-
ated mice that express Cre recombinase in a Sox9-specific
pattern. The perinatal lethality of heterozygous Sox9 mutant
mice precludes the generation of mice in which specific DNAs
are inserted into the coding regions of the Sox9 gene (18, 19).
Thus, to overcome this problem, we inserted IRES-Cre-pA into
the 3-UTR of the Sox9 gene in exon3 just 5 to the polyade-
nylation signal (Fig. 5, which is published as supporting infor-
mation on the PNAS web site). In contrast to Sox9 heterozygous
mutant mice, which died perinatally with cleft palate, respiratory
distress, hypoplasia, and bending of many skeletal structures
derived from cartilage precursors (18, 19), heterozygous Sox9-
Cre knock-in mice were viable and fertile and showed no
noticeable phenotypic changes.
Sox9 Expression Precedes Runx2 and Osx Expression During Limb Bud
Development. Sox9was expressed in the chondrogenic cell lineage
during limb bud development. Indeed, in embryonic day (E)10.0
Sox9 started to be expressed in limb budmesenchyme, then it was
expressed in the cells in mesenchymal condensations and in
chondrocytes (Fig. 1A). In contrast, the expression of Runx2 and
Osx, early markers of the osteogenic cell lineage, was first
detected in E10.5 and E13.5 in limb bud mesenchyme, respec-
tively, and followed Sox9 expression (Fig. 1A), indicating that
Sox9 expression occurs before the determination of an osteo-
genic cell lineage in limb buds.
Sox9-Expressing Limb Bud Mesenchymal Cells Give Rise to Chondro-
cytes and Osteoblasts.We hypothesized that Sox9-expressing limb
bud mesenchymal cells give rise to both the chondrogenic and
osteogenic cell lineages. To confirm this hypothesis, we crossed
Sox9-Cre knock-in mice with R26R mice. Expression of Cre
recombinase in R26R mice results in activation of the lacZ gene,
and, therefore, robust -gal staining provides an indelible
marker of cells that have expressed Sox9 at any time during
development (20–22). In Sox9-Cre;R26R E10.5 embryos, -gal
staining was detected in limb bud mesenchyme, and, in E13.5
embryos, all cells in cartilage primordia and perichondrium were
-gal positive (Fig. 1B). Indeed, the -gal positive region in the
limb buds of Sox9-Cre;R26R embryos was markedly wider than
in the limb buds of Sox9lacZ/wt embryos, which represents only a
chondrogenic cell population (Fig. 1C). In E17.0 limb buds, all
chondrocytes as well as perichondrial, periosteal, and osteoblast
cells were -gal positive (Fig. 1B), indicating that Sox9-
expressing limb bud mesenchymal cells give rise to both chon-
drogenic and osteogenic cell lineages. In addition, -gal positive
cells were detected in tendons and synoviums in E17.0, indicating
that Sox9-expressing limb bud mesenchymal cells also give rise
to tendon cells and synovial cells in limb bud development.
Inactivation of Conditional Osx Alleles by Sox9-Cre Results in Lack of
Bone Formation. Cell fate mapping by using Sox9-Cre knock-in
mice indicated that Sox9-expressing limb bud mesenchymal cells
give rise to osteoblasts. To confirm this result, we generated
mutant mice in which both Osx alleles were inactivated in
Sox9-expressing cells. Osx is a transcription factor that is specif-
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ically expressed in osteoblasts. We recently reported that Osx is
a downstream gene of Runx2 in bone formation and that the
Osx-null mutant mice lack bones completely (15). To generate
the conditional Osx-null mice, we used mice carrying the floxed
Osx allele, in which the DNA segment including exon2 was
flanked by loxP sites (Fig. 2A). Both heterozygous and homozy-
gous animals were viable and fertile and showed no noticeable
phenotypic change. Using the mating scheme described in
Materials and Methods, we produced mutants carrying the Sox9-
Cre gene in which one Osx allele was replaced by the lacZ gene
(15) and the other was replaced by a floxed Osx allele (Fig. 2B).
The conditional Osx-null mutant mice resulting from expression
of the Sox9-Cre gene, which were recovered with the expected
Mendelian frequency, died in the immediate postnatal period
because of the absence of bones. Staining of skeletal prepara-
tions of E17.5 conditional null mutant mice embryos with alcian
blue and alizarin red indicated virtually no mineralization in any
facial and skull bones generated by intramembranous bone
formation, although very small parts of the maxilla, mandible,
and parietal bones were calcified (Fig. 2C). Other skeletal
elements formed by endochondral bone formation, including the
ribs, limb skeletons, and vertebrae, were hypoplastic, bent, and
often deformed, comparable with the phenotype in the Osx-null
mice. Histological analysis showed that the humerus of E17.5
wild-type embryos displayed a typical cellular organization of
bone trabeculae, bone collars, and a zone of hypertrophic
chondrocytes adjacent to the chondro-osseous junction (Fig.
2D). In contrast, the humerus of E17.5 Osx-null and conditional
Osx-null mutant mice had no bone collars and no bone trabec-
ulae. The abnormalities in the humerus were present in all other
endochondral skeletal elements (data not shown).
To better characterize the abnormalities of endochondral
bones in the conditional Osx-null mutant mice, we examined the
expression of the Oc gene, a late osteoblast marker, by in situ
hybridization (Fig. 2E). In E17.5 wild-type embryos, Oc was
strongly expressed in bones. In contrast, Oc was not expressed in
E17.5 Osx-null and conditional Osx-null embryos. Thus, these
results indicate that osteoblast differentiation was arrested in the
mutant embryos in which the Osx gene was inactivated in
Sox9-expressing limb mesenchymal cells. Hence, Sox9-
expressing mesenchymal cells are osteo-chondroprogenitors that
differentiate into both chondrocytes and osteoblasts. The ab-
sence of alizarin red staining in membranous skeletal elements
in Osxflox/LacZ;Sox9-Cre embryos also indicated that Sox9-
expressing cells are the progenitors of osteoblasts in membra-
nous bones.
Paired-Related Homeobox Gene-1 (Prx1)-Expressing Limb Bud Mesen-
chymal Cells Give Rise to All of the Mesenchymal Cell Lineages in Limb
Buds. Prx1 is a homeobox-containing gene that starts to be
expressed in all limb bud mesenchymal cells at E9.0 in advance
of Sox9 (23, 24). Mice homozygous for a mutant Prx1 allele
exhibited the loss or malformation of facial, limb, and vertebral
skeletal structures because of a defect in the formation and
growth of chondrogenic and osteogenic precursors (25). We
previously reported that the conditional Sox9-null mutants
harboring a Prx1-Cre transgene showed a complete lack of both
cartilage and bone in limbs (8). Therefore, these findings
strongly suggest that Prx1-expressing limb bud mesenchymal
cells give rise to Sox9-expressing osteo-chondroprogenitors. In
contrast to the expression of the Prx1 transgene, Sox9 is only
expressed in a subpopulation of limb mesenchymal cells.
Indeed, in Prx1-Cre;R26R embryos (23, 24), all of the cells in
skeletal elements, the fibroblasts in connective tissues, and the
tendon cells and the synovial cells were -gal positive (Fig.
1D). Hence, Prx1-expressing undifferentiated limb bud mes-
enchymal cells differentiate into all of the mesenchymal cell
populations during limb bud development.
Sox9 Defines Progenitors in Testis, Intestine, Spinal Cord, and Pan-
creas During Mouse Embryogenesis.We also examined the fates of
Sox9-expressing cells in other tissues during embryogenesis.
Fig. 1. Comparison of Sox9, Runx2, and Osx expression during embryonic development with lacZ expression in Sox9-Cre;R26R compound heterozygous
embryos. (A) Expression of Sox9, Runx2, and Osx during limb bud development. -gal activity in limb buds of Sox9 heterozygous (Sox9lacZ/wt) (19), Runx2
heterozygous (Runx2lacZ/wt) (14), and Osx heterozygous (OsxlacZ/wt) (15) embryos from E9.5 to E16.5. The arrows indicate the expression of Sox9 in E10.0. The
arrowheads indicate the expression ofRunx2 in E10.5 and E11.5. (B) Sections of limb buds in Sox9-Cre;R26R compound heterozygous embryos from E10.5 to E17.0
stained with whole-mount -gal staining. c, resting and proliferating chondrocytes; h, hypertrophic chondrocytes; p, periosteum; ob, osteoblasts; S, synovium;
T, tendon. (C) Sections of limb buds in Sox9 heterozygous (Sox9lacZ/wt) embryos in E13.5 stained with whole-mount -gal staining. (D) Sections of limb buds in
Prx1-Cre;R26R compound heterozygous embryos in E16.5 with whole-mount -gal staining. The abbreviations are the same as in B.
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Whole-mount -gal staining in Sox9-Cre knock-in;R26R em-
bryos was first detected in E8.0 in notochord, node, and endoder-
mal linings (Fig. 3A). From E10.5, -gal staining was very strong
in nonneural ectoderm throughout embryonic development,
hampering the observation of -gal staining of internal organs.
For this reason, we examined -gal staining in sections made
from paraffin-embedded whole-mount -gal stained E17.0 em-
bryos in which the skin had been removed. In the male gonad,
Sox9 was expressed in Sertoli cells (Fig. 3B). In contrast, all of
the mesenchymal cells including Sertoli cells and Leydig cells in
Sox9-Cre;R26R embryos were -gal positive, but the germ cells
were -gal negative (Fig. 3B). In the intestine, because Sox9 was
expressed in stem cells and progenitor cells in the bottom of
crypts in villi, all of the epithelial cells were -gal positive;
furthermore, the neurogenic cells derived from the neural crest
in which Sox9 was expressed (4, 5, 26) were also -gal positive
(Fig. 3B). In the spinal cord, Sox9 expression was detected
throughout the ventricular neuroepithelial layer in which neural
progenitor cells are located and also in the cells migrating
outward along the dorsoventral axis. Indeed, all of the neural
cells, neurons and glia, in the spinal cord of Sox9-Cre;R26R
embryos were -gal positive. In the pancreas, Sox9was expressed
Fig. 2. Targeting strategy for conditional inactivation of the Osx gene. (A) Structure of the genomic Osx locus, targeting vector, and the homologous
recombined allele. Exons are depicted as filled boxes, and intronic sequences are shown as solid lines. The FRT-flanked PGK-neo bpA and the IRES-EGFP-pA
cassettes are depicted as open boxes. DNA fragments revealed in Southern analysis are indicated as arrows with the restriction enzymes and the probes. RI, EcoRI;
N, NheI; B, BamHI; X, XbaI; RV, EcoRV. (B) Southern blot analysis of genomic DNA. (C–E) Analysis of skeletal phenotypes in Osx flox/lacZ;Sox9-Cre knock-in mice.
Skeletons in E17.5 embryos stained with alcian blue followed by alizarin red showed no mineralization of bones inOsx-null and the conditionalOsx-null mutants
(C). Histological analysis of humerus stained by alcian blue, hematoxylin, and Treosin revealed no bone trabeculae or mineralization in Osx-null and the
conditional Osx-null mutants in E17.5 (D). Expression of Oc mRNA was not detected in humerus of E17.5 Osx-null and the conditional Osx-null mutants (E).
Fig. 3. Comparison of the pattern of cells expressing Sox9 in E17.0 intestine, testis, spinal cord, and pancreas with the pattern of cells that are derived from
Sox9-expressing cells in these embryos. (A) Contribution of Sox9-expressing cells during mouse embryogenesis. -gal activity in Sox9-Cre;R26R compound
heterozygous embryos in E8.0 and E10.5. (B) Comparison between the expression of Sox9, assessed by immunohistochemistry (intestine and testis) of wild-type
embryos or by -gal staining (spinal cord and pancreas) of Sox9 heterozygous (Sox9lacZ/wt) embryos, and the distribution of cells derived from Sox9-expressing
cells in E17.0 Sox9-Cre;R26R embryos. The arrowhead indicates enteric neurons.
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in ductal epithelial cells. In contrast, in Sox9-Cre;R26R embryos,
not only the ductal epithelial cells but also all of the endocrine
and exocrine cells were -gal positive (Fig. 3B). These observa-
tions strongly support the hypothesis that Sox9 defines progen-
itors in these different tissues during mouse embryogenesis.
Discussion
We generated a mouse strain that expresses Cre recombinase in
Sox9-expressing cells during embryogenesis. An IRES-Cre-pA
cassette was inserted into the 3-UTR of the Sox9 gene, resulting
in Cre recombinase expression directly under Sox9 cis-regulatory
control via production of a bicistronic Sox9-Cre recombinase
mRNA. This approach avoided the perinatal lethality of mice
that would have resulted from the insertion of Cre in the coding
portion of Sox9 and inactivation of the Sox9 gene. Expression of
Cre recombinase was assessed by crossing Sox9-Cre knock-in
mice to the Cre-dependent R26R strain. The advantage of using
this genetic system to examine gene expression patterns is that
the R26R strain provides a permanent lineage record through
the constitutive -gal expression in cells that express Cre re-
combinase even transiently in the precursor cells of different cell
lineages (20–22).
During mouse limb development, Sox9 expression was first
detected in a subpopulation of limb mesenchyme in E10.0. In
contrast, Runx2 expression was detected in the lateral plate
mesoderm from E10.5, and Osx expression was seen in limb
mesenchyme from E13.5. These observations strongly suggest
that the osteogenic lineage appeared after Sox9-expressing cells
in limb bud development. Indeed, this hypothesis is supported by
-gal expression in Sox9-Cre knock-in;R26R compound het-
erozygous embryos. In these embryos, -gal expression was
detected in mesenchymal cells before mesenchymal condensa-
tion, whereas after mesenchymal condensations, -gal expres-
sion was found in all of the skeletal components, including not
only the chondrocytes but the perichondrium, the periosteum,
and osteoblasts. Thus, these observations indicate that Sox9-
expressing mesenchymal cells, present before mesenchymal con-
densations occur, are osteo-chondroprogenitors. Indeed, the
inactivation of the Osx gene, which presumably takes place in
Sox9-expressing mesenchymal cells before mesenchymal con-
densations, results in a complete block of osteoblast differenti-
ation. Hence, Sox9 defines osteo-chondroprogenitors in the
mesenchyme of developing limb buds.
We speculate that in endochondral skeletal elements, the
osteogenic lineage cells segregate from Sox9-expressing osteo-
chondroprogenitors at the stage of mesenchymal condensations.
This idea is supported first by histological analysis, which showed
that Sox9 was expressed in limb mesenchymal cells before
mesenchymal condensations (Fig. 1A) (4, 5). In contrast, Runx2
expression was detected at the stage of mesenchymal conden-
sations (Fig. 1A) (27). Second, inactivation of the Sox9 gene in
limb buds before mesenchymal condensations prevented mes-
enchymal condensations and subsequent cartilage and bone
formation, although the Sox9-null cells are present in their
appropriate locations (8). In contrast, Runx2-null mutants form
mesenchymal condensations normally (13, 14). Thus, these
observations strongly suggest that the establishment of an os-
teogenic cell lineage occurs during mesenchymal condensations.
We speculate that in endochondral skeletal elements, the pro-
cess of mesenchymal condensation plays a major role in the
establishment of the osteoblast lineage.
During limb bud development in mouse embryos, undiffer-
entiated limb bud mesenchymal cells that were derived from the
lateral plate mesoderm differentiate and establish mesenchymal
cell lineages, including chondrocytes, osteoblasts, and fibro-
blasts. Previous studies showed that Prx1 is expressed in the early
limb bud mesenchyme in mouse embryos (23) and that Cre
recombinase activity is present in all mesenchymal cells, includ-
ing osteo-chondroprogenitors, in E10.5 forelimb buds of Prx1-
Cre transgenic mice (24). In E16.5 Prx1-Cre;R26R compound
heterozygous embryos, -gal activity was detected in all of the
skeletal elements, including chondrocytes, perichondrium, peri-
osteum, and osteoblasts, and all fibroblasts in connective tissues,
tendon cells, and synovial cells. In these embryos, muscle and
skin did not stain for -gal, indicating that these cell lineages do
not derive from Prx1-Cre expressing cells in limb buds (data not
shown). In Sox9-Cre;R26R embryos not all tendon cells stained
for -gal. The difference between -gal staining of tendons in
Prx1-Cre;R26R and that of tendons in Sox9-Cre;R26R embryos
may be due to the activation of the Prx1 promoter at the tendon
insertion points of the skeletal muscles (23). We therefore
concluded that Prx1-expressing undifferentiated limb bud mes-
enchyme gives rise to all mesenchymal cell populations, includ-
ing Sox9-expressing osteo-chondroprogenitors, which differen-
tiate into Sox9-expressing chondrocytes and Runx2-expressing
osteoblasts during limb development (Fig. 4).
The absence of membranous bones in Osxflox/LacZ;Sox9-Cre
embryos indicates that osteoblasts in membranous bones in the
skull derive from Sox9-expressing precursor cells. In previous
experiments, we used Wnt1-Cre to inactivate Sox9 in delaminat-
ing cranial neural crest cells before frank emigration. In these
embryos, endochondral bones did not form, but intramembra-
nous bone formed normally (26). Together, these findings
suggest that the segregation of two of the skeletal lineages arising
from Sox9-expressing cranial neural crest cells, namely osteo-
blast progenitors of membranous bones and chondrocyte pre-
cursors of endochondral bones, occurs in the cranial neural crest
before the expression of Wnt-1 Cre and, thus, before emigration
of neural crest cells.
In Sox9-Cre;R26R compound heterozygous mice, -gal ex-
pression was detected first in E8.0 embryos in node and
notochord, and then in neural crest and its derivatives, includ-
ing skin and dorsal root ganglia. Comparison of -gal expres-
sion with Sox9 expression revealed that Sox9-expressing cells
gave rise to all mesenchymal cell lineages in the testis. Sox9-
expressing cells also gave rise to all cell lineages in the spinal
cord, pancreas, and epithelium of the intestines. These obser-
vations therefore indicate that Sox9 is expressed in the pro-
genitor cells of all of the cells that are present later in these
tissues of mouse embryos. In addition, Sox9 may play crucial
roles in cell proliferation and differentiation of these progen-
itors. Indeed, Sox9-null cells in the testis, spinal cord, and
pancreas do not proliferate nor differentiate, as do wild-type
Sox9-expressing cells in these tissues (H.A., unpublished data;
refs. 28 and 29).
Fig. 4. Model of establishment of mesenchymal cell lineages during limb
bud development. Prx1-expressing undifferentiated limb bud mesenchyme
gives rise to Sox9-expressing osteo-chondroprogenitors, fibroblasts, tendon
cells, and synovial cells. These Sox9-expressing osteo-chondroprogenitors
form mesenchymal condensations, in whichRunx2-expressing osteogenic cells
are separated from Sox9-expressing chondrocytes.
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